---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-035618"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:04:14.523591+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech VERSATILE-002 abstract accepted for ESMO 2024 presentation

## Summary
- Abstract on first-line Versamune HPV + KEYTRUDA in HPV16-positive recurrent/metastatic HNSCC accepted for ESMO.
- Poster number 879P; session at ESMO Congress 2024 in Barcelona, Sept 13-17.
- Presenting author: Dr. Jared Weiss, Section Chief at UNC and trial PI.
- Poster title includes survival data; no clinical results disclosed in this release.

## SEC filing metadata
- accession: 0001140361-24-035618
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/0001140361-24-035618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/ef20033543_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-035618
- JSON: https://secwatch.observer/filing/0001140361-24-035618.json
- Plain text: https://secwatch.observer/filing/0001140361-24-035618.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.